Amy L. Burroughs's Net Worth

$14.9 Thousand

Estimate Recalculated Jul 2, 2024 05:40PM EST

Who is Amy L. Burroughs?

Amy L. Burroughs does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DiaMedica Therapeutics Inc., and Tenaya Therapeutics, Inc..

SEC CIK

Amy L. Burroughs's CIK is 0001872564

Past Insider Trading and Trends

2022 was Amy L. Burroughs's most active year for acquiring shares with 3 total transactions. Amy L. Burroughs's most active month to acquire stocks was the month of December. 2021 saw Amy L. Burroughs paying a total of $141,592.50 for 63,736 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DiaMedica Therapeutics Inc. (DMAC) Snapshot price: $3.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+30.56%
17.16K
$1.53
$26,248.68
73.29K
Jan 3
Form 4
—
0
—
—
0
Jun 1
Form 4
+24.88%
11.18K
$3.58
$40,031.56
56.13K
Jan 3
Form 4
∞
44.95K
$3.15
$141,592.50
44.95K
Aug 16
Form 4
—
0
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found

Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $4.415

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 5
Form 3
—
0
—
—
0
No matching records found

Terns Pharmaceuticals, Inc. (TERN) No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found